International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson's Disease Clinical Trial
CARLSBAD, CA--(Marketwired - Nov 13, 2017) - International Stem Cell Corporation (OTCQB: ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today the positive six months …